UnitedHealth Group Incorporated
UNH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.93 | 1.82 | 1.41 | 2.18 |
| FCF Yield | 4.41% | 5.26% | 4.73% | 4.20% |
| EV / EBITDA | 18.58 | 14.60 | 16.63 | 18.40 |
| Quality | ||||
| ROIC | 12.32% | 14.29% | 13.96% | 13.85% |
| Gross Margin | 22.33% | 24.48% | 24.56% | 24.22% |
| Cash Conversion Ratio | 1.59 | 1.30 | 1.30 | 1.29 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.28% | 8.92% | 8.03% | 5.90% |
| Free Cash Flow Growth | -19.38% | 9.73% | 17.67% | -1.16% |
| Safety | ||||
| Net Debt / EBITDA | 1.84 | 1.16 | 1.08 | 0.91 |
| Interest Coverage | 8.27 | 9.97 | 13.59 | 14.44 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -36.31 | -3.29 | -64.83 | -64.23 |